The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
 
Fredrik Schjesvold
Honoraria - Amgen; Sanofi; Takeda
Consulting or Advisory Role - Celgene; Janssen; Oncopeptides; Sanofi
Research Funding - Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Sanofi
 
Vadim Doronin
Honoraria - Janssen; Sanofi; Takeda
Consulting or Advisory Role - Celgene; Janssen; Sanofi
Research Funding - Agios; Celgene; Janssen; Pfizer; Sanofi
 
Olga Vinogradova
Honoraria - Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Sanofi
 
HANG QUACH
Honoraria - Amgen; Antengene; Bristol-Myers Squibb; Celgene; CSL Behring; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi; Takeda
Speakers' Bureau - Amgen; Antengene; Bristol-Myers Squibb; Celgene; CSL Behring; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi; Takeda
Research Funding - Amgen; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Gonzalez montes Yolanda
No Relationships to Disclose
 
Karthik Ramasamy
Honoraria - Amgen; Bristol-Myers Squibb; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol-Myers Squibb; GlaxoSmithKline UK Ltd.; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Speakers' Bureau - Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Takeda
 
Alessandra Pompa
Honoraria - Amgen; Celgene; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Janssen; Roche; Takeda
 
Mark-David Levin
Honoraria - AbbVie; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Janssen; Takeda
 
Cindy Lee
Employment - SA Health
Consulting or Advisory Role - Janssen
Research Funding - BMS Brazil
 
Ulf-Henrik Mellqvist
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Oncopeptides
 
Roland Fenk
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen
 
Hamdi Sati
Honoraria - Janssen; Novartis; Takeda
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Takeda
 
Alexander Vorog
No Relationships to Disclose
 
Richard J. Labotka
Employment - Takeda
 
Jichang Du
Employment - Takeda
 
Mohamed Darif
Employment - Takeda
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)